Matches in Wikidata for { <http://www.wikidata.org/entity/Q61966181> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q61966181 description "clinical trial" @default.
- Q61966181 description "ensayo clínico" @default.
- Q61966181 description "ensayu clínicu" @default.
- Q61966181 description "klinisch onderzoek" @default.
- Q61966181 description "клінічне випробування" @default.
- Q61966181 description "临床试验" @default.
- Q61966181 name "Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications" @default.
- Q61966181 type Item @default.
- Q61966181 label "Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications" @default.
- Q61966181 prefLabel "Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications" @default.
- Q61966181 P1050 Q61966181-26AF43DD-0ED9-4FEB-9372-5263488E4012 @default.
- Q61966181 P1050 Q61966181-8F432192-C291-42FA-842F-CADD52A78D49 @default.
- Q61966181 P1050 Q61966181-C0CFE268-44C1-4138-8E7C-FFC11D982CC6 @default.
- Q61966181 P1132 Q61966181-68EC52FA-FB0C-44AA-A1A5-AEFFD1EBCBE6 @default.
- Q61966181 P131 Q61966181-E6732E4E-6F7B-4FC7-90E3-82640FC9F112 @default.
- Q61966181 P1476 Q61966181-5C68F338-ACE7-469E-99D1-6848360E867A @default.
- Q61966181 P17 Q61966181-2A38DCE1-39F5-4D22-9E7B-6EE20FF85B42 @default.
- Q61966181 P17 Q61966181-CEED266D-EA29-49F9-8AC2-64CE61CBF76E @default.
- Q61966181 P2899 Q61966181-AF6194FF-AF24-441B-BFDD-729DF57F4325 @default.
- Q61966181 P3098 Q61966181-8869E0CF-C23F-40E5-A6B9-81BE989E498A @default.
- Q61966181 P31 Q61966181-A530862A-528A-429F-BF59-DF893F1FDA37 @default.
- Q61966181 P4844 Q61966181-4B6558C9-D3B8-4DE5-9ECC-2403F865124F @default.
- Q61966181 P580 Q61966181-7B874C23-E837-41D5-9B82-CBC2C5DDBB5A @default.
- Q61966181 P582 Q61966181-7912B779-4D1A-49E5-AB3B-283A081361CC @default.
- Q61966181 P6099 Q61966181-E0E98F78-9040-4103-AC2C-1B2A75F3AA0D @default.
- Q61966181 P6153 Q61966181-3147BBFD-61EB-4319-BFC6-B52CD76D327F @default.
- Q61966181 P6153 Q61966181-8AC14EAD-6662-4C2A-AC33-787AA73FE022 @default.
- Q61966181 P6153 Q61966181-BE3179E4-1B7E-46DF-809C-BAA338246A82 @default.
- Q61966181 P8005 Q61966181-CAB9E7CC-9A75-4DB5-A1B6-232A133ED49C @default.
- Q61966181 P8363 Q61966181-94B157EA-93B8-4748-A288-AD9E78600656 @default.
- Q61966181 P859 Q61966181-2CFC78CB-BECE-4459-8539-423DBA63673D @default.
- Q61966181 P1050 Q131742 @default.
- Q61966181 P1050 Q154869 @default.
- Q61966181 P1050 Q157661 @default.
- Q61966181 P1132 "+320" @default.
- Q61966181 P131 Q1183 @default.
- Q61966181 P1476 "Open-Label, Multiple-Dose, Dose Escalation Study to Evaluate the Pharmacodynamics, Pharmacokinetics, and Safety of Coadministration of BMS-650032, BMS-790052, and BMS-791325 When Administered for 24 or 12 Weeks in Treatment-Naïve Subjects Infected With Hepatitis C Virus Genotype 1" @default.
- Q61966181 P17 Q142 @default.
- Q61966181 P17 Q30 @default.
- Q61966181 P2899 "+18" @default.
- Q61966181 P3098 "NCT01455090" @default.
- Q61966181 P31 Q30612 @default.
- Q61966181 P4844 Q421862 @default.
- Q61966181 P580 "2011-11-30T00:00:00Z" @default.
- Q61966181 P582 "2014-03-31T00:00:00Z" @default.
- Q61966181 P6099 Q42824440 @default.
- Q61966181 P6153 Q193727 @default.
- Q61966181 P6153 Q30270271 @default.
- Q61966181 P6153 Q333886 @default.
- Q61966181 P8005 Q76651189 @default.
- Q61966181 P8363 Q78089383 @default.
- Q61966181 P859 Q266423 @default.